• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical pharmacokinetics of theophylline during co-treatment with cefaclor.

作者信息

Jonkman J H, van der Boon W J, Schoenmaker R, Holtkamp A, Hempenius J

出版信息

Int J Clin Pharmacol Ther Toxicol. 1986 Feb;24(2):88-92.

PMID:3957498
Abstract

The effect of cefaclor on the steady state pharmacokinetics of theophylline was investigated in healthy young adults by comparing the pharmacokinetic parameters as found during a nine days course of theophylline alone and as obtained during co-medication with the antibiotic cefaclor. The pharmacokinetic parameters obtained on Day 9 during the two periods of drug treatment accounted for the following figures respectively: minimum plasma concentration 5.0 +/- 1.7 mg X 1(-1) (mean +/- SD) and 6.0 +/- 2.0 mg X 1(-1); maximum plasma concentration 9.7 +/- 2.6 mg X 1(-1) and 9.0 +/- 2.6 mg X 1(-1); time to peak 3.2 +/- 0.4 h and 3.9 +/- 0.8 h; AUC 132.54 +/- 41.73 mg X 1(-1) X h and 126.90 +/- 40.45 mg X 1(-1) X h; half-life of elimination 6.6 +/- 1.6 h and 7.1 +/- 1.2 h; clearance 0.059 +/- 0.011 1 X h-1 X kg-1 and 0.063 +/- 0.014 1 X h-1 X kg-1; volume of distribution 0.54 +/- 0.09 1 X kg-1 and 0.64 +/- 0.17 1 X kg-1. Only the values for cmax and tmax after cefaclor co-treatment were slightly, but significantly (p less than 0.05) different from the values found after administration of theophylline alone. As the volume of distribution and the clearance were not affected by cefaclor, it is concluded that both drugs can be given concomitantly without any dosage adjustment of theophylline.

摘要

相似文献

1
Clinical pharmacokinetics of theophylline during co-treatment with cefaclor.
Int J Clin Pharmacol Ther Toxicol. 1986 Feb;24(2):88-92.
2
No effect of cefaclor on theophylline pharmacokinetics.
Eur J Respir Dis. 1985 Jan;66(1):47-9.
3
Impact of cefaclor on the pharmacokinetics of theophylline.头孢克洛对茶碱药代动力学的影响。
Ther Drug Monit. 1986;8(2):151-4. doi: 10.1097/00007691-198606000-00004.
4
Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine.茶碱以及H2拮抗剂药物西咪替丁和雷尼替丁的药代动力学。
Int J Clin Pharmacol Ther Toxicol. 1984 Apr;22(4):221-6.
5
Safety: cimetidine and concomitant theophylline or warfarin--drug interactions and their implications.
Clin Ther. 1986;8 Suppl A:57-68.
6
In vitro activity and pharmacokinetics of cefaclor in normal volunteers and patients with renal failure.头孢克洛在正常志愿者和肾衰竭患者中的体外活性及药代动力学
Postgrad Med J. 1979;55 Suppl 4:12-6.
7
Cimetidine-theophylline interaction: effects of age and cimetidine dose.西咪替丁 - 茶碱相互作用:年龄和西咪替丁剂量的影响。
Ther Drug Monit. 1985;7(4):426-34.
8
Clopidogrel does not affect the pharmacokinetics of theophylline.氯吡格雷不影响茶碱的药代动力学。
Semin Thromb Hemost. 1999;25 Suppl 2:65-8.
9
Clinical pharmacokinetics of five oral cephalosporins in calves.五种口服头孢菌素在犊牛体内的临床药代动力学
Res Vet Sci. 1987 Sep;43(2):166-72.
10
[Pharmacokinetics of theophylline and circadian rhythm].[茶碱的药代动力学与昼夜节律]
Pathol Biol (Paris). 1982 Dec;30(10):851-4.

引用本文的文献

1
Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.内源性和外源性效应物对茶碱药代动力学的影响。重点关注生物转化。
Clin Pharmacokinet. 1995 Apr;28(4):287-314. doi: 10.2165/00003088-199528040-00003.
2
Pharmacokinetic interactions between theophylline and other medication (Part II).茶碱与其他药物之间的药代动力学相互作用(第二部分)。
Clin Pharmacokinet. 1991 Feb;20(2):135-50. doi: 10.2165/00003088-199120020-00005.